Flaxseed, Aromatase Inhibitors and Breast Tumor Characteristics (FABrC)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
AstraZeneca
Information provided by (Responsible Party):
Roswell Park Cancer Institute
ClinicalTrials.gov Identifier:
NCT00612560
First received: February 7, 2008
Last updated: October 8, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)